An agency of the European Union Enpr-EMA European Network of Paediatric Research at the European Medicines Agency Background information Irmgard Eichler,
What are the risks and benefits of Tyrosine Kinase I nhibitors ?
What are the risks and benefits of Tyrosine Kinase Inhibitors ? Wendy Osborne Consultant Haematologist Freeman Hospital, Newcastle.
